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Aluminium foil for smoking drugs 
                   A briefing for commissioners and providers of services for people who use drugs 
 
 
On 8 August 2014 legislation was laid that will permit drug services to provide 
aluminium foil to drug users for the purpose of smoking1 drugs, in order to reduce the 
harms caused by injecting. It is a condition that foil can only be provided in the 
context of structured steps either to engage people in a treatment plan or as part of a 
treatment plan. This briefing explains more about the legislation that will come into 
force on 5 September 2014 and provides advice to local areas on its implementation. 
 
Background 
The 2010 drug strategy contains a clear ambition that more drug users will be 
supported to become drug free. It also supports the continued prevention of blood-
borne virus transmission and drug-related deaths in those who continue to use drugs. 
The Advisory Council on the Misuse of Drugs (ACMD) advised government that the 
balance of benefit from providing foil for the purposes of smoking controlled 
substances favoured exempting it from Section 9A of the Misuse of Drugs Act 1971. 
The Home Secretary announced in 2013 that the government had “accepted the 
advice of the ACMD to allow for the lawful provision of foil by drug treatment 
providers subject to the strict condition that it is part of structured efforts to get people 
into treatment and off drugs.” 
 
The benefits and risks of using foil for smoking drugs 
Services provide aluminium foil to prevent or reverse the transition to injecting drugs, 
and so prevent the infections and other harms than can result from injecting. It is 
offered to encourage people into treatment and on the road to recovery from drug 
dependence.  
 
1
 “Smoking” is used throughout this briefing to mean heating a drug on foil and inhaling its vapours. 
Other guidance may refer only to “inhalation” but mean the same thing. 
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Services should note – and explain to service users – that, although smoking drugs 
from foil will prevent many of the infection and other hazards associated with 
injecting, it carries its own risks. Smoking heroin will not prevent infection from 
bacteria such as anthrax and tuberculosis if the bacteria are present in the heroin. 
Smoking drugs can also cause thermal damage to the throat and lungs from the heat 
of the smoke. And inhaling drugs and their impurities can be damaging in itself with, 
for example, heroin causing asthma-like breathing difficulties. 
Services will likely want to supply foil specifically designed for drug use. There is no 
evidence of harm from using household foil but some users say it irritates their lungs. 
 
Current arrangements for providing foil 
In some parts of the country, services already provide foil to people to smoke drugs, 
where local police or prosecutors have provided a ‘letter of comfort’. Services 
considering relying on these letters of comfort after the legislation has changed are 
advised to seek legal advice. However, the expectation is that service providers 
supplying, or offering to supply, foil after the legislative change will do so in 
compliance with the conditions set out in the legislation. 
 
Monitoring the future provision of foil 
The provision of foil will be monitored in two main ways: 
1 New fields have been added to the national Needle Exchange Monitoring 
System (NEXMS) to record the number of foil sheets issued and the number 
of people taking them, including both the number only taking foil and the 
number taking foil and other injecting equipment. For more information, see 
the NEXMS guidance at www.nta.nhs.uk/nexmsguidance.aspx 
Services using paper, PC or web-based monitoring systems other than 
NEXMS will want to consider adding matching data fields. 
Public Health England is encouraging the increased use of NEXMS and 
considering the possibility of introducing a facility for data to be uploaded to 
NEXMS from local NSP monitoring systems. PHE will also be conducting a 
longer-term review of the monitoring of non-structured interventions with drug 
users in England. 
2 In early 2015 the Home Office will be undertaking interviews with service 
providers at a sample of NSP sites to gain a more detailed understanding of 
the process through which foil is provided. 
PHE and the Home Office will also monitor sales of aluminium foil from specialist 
suppliers. 
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The conditions for providing foil 
The new legislation provides that: 
“a person employed or engaged in the lawful provision of drug treatment services 
may, when acting in their capacity as such, supply or offer to supply aluminium foil in 
the context of structured steps (a) to engage a person in a drug treatment plan or (b) 
which form part of a patient’s treatment plan” 
The various stipulations in this legislation are discussed below. 
“a person employed or engaged in the lawful provision of drug treatment 
services” 
The Misuse of Drugs Regulations 2001 currently allows practitioners, pharmacists 
and persons employed or engaged in the lawful provision of drug treatment services 
to supply swabs, spoons and cups (for drug preparation), citric acid, filters and water 
for injection. The provision for foil is more restrictive as it may only be supplied by the 
last of these, that is, “a person employed or engaged in the lawful provision of drug 
treatment services”. A person engaged in needle and syringe provision, including in a 
community pharmacy, is providing drug treatment and would be able to provide foil if 
they also met the other conditions described in the next section. 
“in the context of structured steps (a) to engage a person in a drug 
treatment plan or (b) which form part of a patient’s treatment plan” 
This is an additional requirement, which does not apply to the supply of swabs, 
spoons and other injecting supplies. 
Structured steps “to engage a person in a drug treatment plan” 
Those providing the foil must have in mind, or in writing, a clear set of actions for 
engaging a person in treatment. Available actions might include discussion about 
treatment, signposting to treatment services, making available relevant information, 
and providing motivational or practical support to engage in treatment. 
Face-to-face communication will be an important element of these actions – the 
distribution of leaflets and posters, for example, will not be sufficient. 
Structured steps “which form part of a patient’s treatment plan” 
A very wide range of steps is likely to be available when foil is provided as part of a 
treatment plan, and the provision of foil can be recorded as part of the overall plan of 
care. 
It is likely that foil will usually only need to be provided in the initial stages of 
treatment, when a service user is transitioning from injecting heroin to smoking it as 
an interim step to ending its use. However, it might be important on occasion to 
provide foil later in someone’s treatment, at a time when they are at risk of relapse, to 
help them avoid returning to injecting. 
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“treatment plan” 
The legislation further defines a drug treatment plan as “a written plan, relating to the 
treatment of an individual patient, and agreed by the patient and the person 
employed in the lawful provision of drug treatment services”. A written plan is not a 
requirement at the stage of taking steps to engage someone in a treatment plan. 
 
Vending machines and secondary distribution 
It seems unlikely that foil could be provided from vending machines and the 
conditions met. 
Secondary distribution – in which supplies are given to one service user to pass onto 
others – might only be considered to meet the conditions where it is evident that the 
foil is being passed on to an individual for whom structured steps are already 
underway to engage them in treatment. 
 
What services and their staff can do to support 
appropriate supply of foil 
Services providing foil can: 
 provide health promotion services, for example, blood-borne virus 
screening, vaccination and sexual health advice 
 ensure staff are aware of the respiratory complications of smoking from 
foil, and can provide advice on this and signpost to services for further 
screening if required 
 ensure staff have the competences to assess risk-taking behaviour 
including injecting risk, articulate the risks versus the benefits of safer 
alternatives such as smoking, and support changes that support a 
reduction in risk 
 ensure suitable information about access to treatment services is 
available 
Staff in services providing foil can: 
 encourage people who inject drugs to switch to less harmful methods of 
drug use eg smoking 
 offer advice on the symptoms and signs of a chest infection so that early 
treatment can be obtained if needed 
 be aware of those individuals with associated respiratory comorbidity 
through careful assessment and ensure that they have active respiratory 
self-management plans in place and are regularly accessing 
COPD/asthma clinics in primary care as appropriate 
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 be aware of the strong association of opiate and crack use with tobacco 
smoking, and encourage individuals to consider stopping smoking 
tobacco through access to stop smoking services or with GP support 
(introducing them to the range of interventions available to assist people 
to quit) 
 be ready to address any concerns about drug smoking’s lesser 
effectiveness and increased cost, and any previous negative experiences 
of smoking drugs 
 capitalise on times when injecting becomes less feasible or attractive to 
the individual, or when a move to smoking may be more attractive, such 
as: 
o periods of restricted venous access 
o when considering or having recently moved to femoral or other 
dangerous injecting 
o when experiencing significant harms associated with femoral or other 
deep vein injecting 
o on release from prison or after recent detoxification, which are also 
times when services may want to ensure that the service user has a 
supply of naloxone to help protect against the increased risk of 
overdose 
o newly initiated to injecting where tolerance levels may be low or 
behaviour less fixed 
 provide information, discuss treatment options, signpost to local services 
and provide encouragement and support to service users to engage in a 
treatment plan; or to progress their current treatment plan further away 
from harmful drug use and towards their fullest recovery 
 
Other sources of information 
ACMD reports: 
2010 – Consideration of the use of foil as an intervention to reduce the harms 
of heroin www.gov.uk/government/publications/foil-report 
2011 – Further advice on the risks of physical harms: Consideration of the use 
of foil as an intervention to reduce the harms of heroin and cocaine 
www.gov.uk/government/publications/acmd-consideration-of-the-use-of-foil-
as-an-intervention-to-reduce-the-harms-of-heroin-and-cocaine-december-2011 
2013 – Further advice about whether the provision of foil assists individuals in 
achieving recovery: Consideration of the use of foil as an intervention to 
support recovery www.gov.uk/government/publications/acmd-further-advice-
on-foil-2013 
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The Home Secretary’s 2013 written statement to Parliament on the government's 
acceptance of ACMD advice on the lawful provision of foil 
www.gov.uk/government/speeches/drug-paraphernalia 
Hunt N & Pizzey R (2008) Distributing foil from needle and syringe programmes 
(NSPs) to promote transitions from heroin injecting to chasing: An evaluation. Harm 
Reduct J. 2008; 5: 24. www.harmreductionjournal.com/content/5/1/24 
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